Scroll To Top

FDA Approves Neuropathy Treatment

FDA Approves Neuropathy Treatment


The Food and Drug Administration recently approved Gamunex, an immune globulin intravenous therapy, for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a condition characterized by progressive weakness and impaired sensory function in the arms and legs. Immune globulin products are obtained from pooled human blood plasma, which contains infection-fighting antibodies, and are often given to HIVers at risk for certain infectious diseases. It is estimated that CIDP affects about 25,000 Americans.

Out Subscription Lil Nas XAdvocateChannel promotion

From our Sponsors

Most Popular

Fifth Person Cured of HIV

Latest Stories